Mnemo Therapeutics

Developer of cell therapy platforms for tumors and blood cancer

placeParis, Ile De France, France calendar_todayFounded 2018 groups56 employees language mnemo-tx.com

Innovation

11 patent families (1 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace steady. Cited 2,125 times.

YearFilings
20212
20225
20236
20247
20258

Investor mix

5 investors on record; lead investors include Casdin Capital, Sofinnova Partners.

Investor typeCountShare
Venture capital240%
Other / undisclosed360%
Coming soon